Search - tctmd.com

Displaying 161 - 180 of 228

Sort: Relevancy | Date

News Daily News

大规模登记研究表明 Amplatzer 封堵器能够减少房颤患者的卒中和出血风险

February 17, 2015

News Daily News

Un Amplio Estudio de Registro Sugiere que el Enchufe Amplatzer Reduce los Riesgos Hemorrágico y de ACV en el Manejo de la FA

February 17, 2015

News Daily News

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

February 17, 2015

LAA Occlusion for Stroke Prevention in A-Fib

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

January 28, 2015

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Presentation

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Presenter: AO Badheka

December 11, 2014

News Daily News

Hospital Volume Linked to More Favorable LAA Closure Outcomes

December 11, 2014

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

November 19, 2014

News Daily News

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Yael L. Maxwell

November 06, 2014

News Daily News

得到的FDA专家组支持率低，Watchman可能为时不多了

October 16, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

October 16, 2014

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Presentation TCT 2014

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Presenter: Vivian Lee

September 16, 2014

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Presentation TCT 2014

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Presenter: George Hanzel

September 16, 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Presentation TCT 2014

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Jonathan L. Halperin

September 15, 2014

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Presentation TCT 2014

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Stefan C. Bertog

September 15, 2014

Can LAA Closure Become the New Standard for Stroke Prevention?

Presentation TCT 2014

Can LAA Closure Become the New Standard for Stroke Prevention?

Presenter: Hilary Nierenberg, Julie Logan, Saibal Kar

September 14, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Daily News

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Yael L. Maxwell

August 07, 2014

Left Atrial Appendage Closure (LAAC) for Stroke Prevention in Non-Valvular AFib: My Preferred Frontline Therapy

Presentation LAA 2014

Left Atrial Appendage Closure (LAAC) for Stroke Prevention in Non-Valvular AFib: My Preferred Frontline Therapy

Presenter: Maurice Buchbinder

July 19, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.